Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge

Infection and Immunity

Volumn 72, Issue 6, 2004, Pages 3336-3343

  Varaldo, Paula B ^a   Leite, Luciana C C ^a   Dias, Waldely O ^a   Miyaji, Eliane N ^a   Torres, Fabio I G ^a   Gebara, Vera C ^a   Armôa, Geraldo R G ^b   Campos, Adriano S ^b   Matos, Denise C S ^b   Winter, Nathalie ^d   Gicquel, Brigitte ^d   Vilar, Mônica M ^b   McFadden, Johnjoe ^e   Almeida, Marilia S ^c   Tendler, Miriam ^b   McIntosh, Douglas ^b,f  

^a INSTITUTO BUTANTAN   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^d INSTITUT PASTEUR   (France)

^e UNIVERSITY OF SURREY   (United Kingdom)

^f Research and Productivity Council   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BETA LACTAMASE; GAMMA INTERFERON; SCHISTOSOMA VACCINE; SM14 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; CATTLE; CERCARIA; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MOLECULAR CLONING; MONOCYTE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM FORTUITUM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SCHISTOSOMA MANSONI; SPLEEN CELL; TH1 CELL;

ANIMALS; ANTIBODIES, HELMINTH; BETA-LACTAMASES; CARRIER PROTEINS; CATTLE; CELLS, CULTURED; FATTY ACID TRANSPORT PROTEINS; FEMALE; HELMINTH PROTEINS; INTERFERON TYPE II; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED BALB C; MONOCYTES; MYCOBACTERIUM BOVIS; MYCOBACTERIUM FORTUITUM; RECOMBINANT FUSION PROTEINS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINES, DNA;

EID: 2542550555     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.6.3336-3343.2004     Document Type: Article

References (32)

1. Abdelhak, S., H. Louzir, J. Timm, L. Blel, Z. Benlasfar, M. Lagranderie, M. Gheorghiu, K. Dellagi, and B. Gicquel. 1995. Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice. Microbiology 141:1585-1592.
2. Aldovini, A., and R. A. Young. 1991. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 351:479-482.
3. Aldwell, F. E., D. N. Wedlock, L. J. Slobbe, J. F. Griffin, B. M. Buddle, and G. S. Buchan. 2001. In vitro control of Mycobacterium bovis by macrophages. Tuberculosis (Edinburgh) 81:115-123.
4. Baulard, A., C. Jourdan, A. Mercenier, and C. Locht. 1992. Rapid mycobacterial plasmid analysis by electroduction between Mycobacterium spp. and Escherichia coli. Nucleic Acids Res. 20:4105.
5. Bergquist, N. R. 1998. Schistosomiasis vaccine development: progress and prospects. Mem. Inst. Oswaldo Cruz 93(Suppl. 1):95-101.
6. Bergquist, N. R. 2002. Schistosomiasis: from risk assessment to control. Trends Parasitol. 18:309-314.
7. Brandt, L., J. Feino Cunha, A. Weinreich Olsen, B. Chilima, P. Hirsch, R. Appelberg, and P. Andersen. 2002. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70:672-678.
8. Brito, C. F., I. R. Caldas, P. Coura Filho, R. Correa-Oliveira, and S. C. Oliveira. 2000. CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14kDa Schistosoma mansoni fatty acid-binding protein. Scand. J. Immunol. 51:595-601.
9. Brito, C. F., C. T. Fonseca, A. M. Goes, V. Azevedo, A. J. Simpson, and S. C. Oliveira. 2000. Human IgG1 and IgG3 recognition of Schistosoma mansoni 14kDa fatty acid-binding recombinant protein. Parasite Immunol. 22:41-48.
10. Buddle, B. M., B. J. Wards, F. E. Aldwell, D. M. Collins, and G. W. de Lisle. 2002. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 20:1126-1133.
11. Coulson, P. S., and R. A. Wilson. 1997. Recruitment of lymphocytes to the lung through vaccination enhances the immunity of mice exposed to irradiated schistosomes. Infect. Immun. 65:42-48.
12. Dalton, J. P., S. McGonigle, T. P. Rolph, and S. J. Andrews. 1996. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. Infect. Immun. 64:5066-5074.
13. Edelman, R., K. Palmer, K. G. Russ, H. P. Secrest, J. A. Becker, S. A. Bodison, J. G. Perry, A. R. Sills, A. G. Barbour, C. J. Luke, M. S. Hanson, C. K. Stover, J. E. Burlein, G. P. Bansal, E. M. Connor, and S. Koenig. 1999. Safety and immunogenicity of recombinant bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine. Vaccine 17:904-914.
14. Gebara, V. C., V. L. Petricevich, I. Raw, and W. D. da Silva. 1995. Effect of saponin from Quillaja saponaria (molina) on antibody, tumour necrosis factor and interferon-gamma production. Biotechnol. Appl. Biochem. 22:31-37.
15. Grode, L., M. Kursar, J. Fensterle, S. H. Kaufmann, and J. Hess. 2002. Cell-mediated immunity induced by recombinant Mycobacterium bovis bacille Calmette-Guerin strains against an intracellular bacterial pathogen: importance of antigen secretion or membrane-targeted antigen display as lipoprotein for vaccine efficacy. J. Immunol. 168:1869-1876.
16. Hanson, M. S., C. V. Lapcevich, and S. L. Haun. 1995. Progress on development of the live BCG recombinant vaccine vehicle for combined vaccine delivery. Ann. N. Y. Acad. Sci. 754:214-221.
17. Himmelrich, H., R. Lo-Man, N. Winter, P. Guermonprez, C. Sedlik, M. Rojas, D. Monnaie, M. Gheorghiu, M. Lagranderie, M. Hofnung, B. Gicquel, J. M. Clement, and C. Leclerc. 2000. Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: male. Vaccine 18:2636-2647.
18. Kremer, L., L. Dupre, G. Riveau, A. Capron, and C. Locht. 1998. Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing glutathione S-transferase from Schistosoma haematobium. Infect. Immun. 66:5669-5676.
19. Kremer, L., G. Riveau, A. Baulard, A. Capron, and C. Locht. 1996. Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guerin producing the Schistosoma mansoni glutathione S-transferase. J. Immunol. 156:4309-4317.
20. Lagranderie, M., R. Lo-Man, E. Deriaud, B. Gicquel, M. Gheorghiu, and C. Leclerc. 1997. Genetic control of antibody responses induced by recombinant Mycobacterium bovis BCG expressing a foreign antigen. Infect. Immun. 65:3057-3064.
21. Le Dantec, C., N. Winter, B. Gicquel, V. Vincent, and M. Picardeau. 2001. Genomic sequence and transcriptional analysis of a 23-kilobase mycobacterial linear plasmid: evidence for horizontal transfer and identification of plasmid maintenance systems. J. Bacteriol. 183:2157-2164.
22. Lim, E. M., J. Rauzier, J. Timm, G. Torrea, A. Murray, B. Gicquel, and D. Portnoi. 1995. Identification of Mycobacterium tuberculosis DNA sequences encoding exported proteins by using phoA gene fusions. J. Bacteriol. 177:59-65.
23. Moser, D., M. Tendler, G. Griffiths, and M. Q. Klinkert. 1991. A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins. J. Biol. Chem. 266:8447-8454.
24. Nascimento, I. P., W. O. Dias, R. P. Mazzantini, E. N. Miyaji, M. Gamberini, W. Quintilio, V. C. Gebara, D. F. Cardoso, P. L. Ho, I. Raw, N. Winter, B. Gicquel, R. Rappuoli, and L. C. Leite. 2000. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice. Infect. Immun. 68:4877-4883.
25. Ohara, N., and T. Yamada. 2001. Recombinant BCG vaccines. Vaccine 19:4089-4098.
26. Parish, T., and N. G. Stoker. 1995. Electroporation of mycobacteria. Methods Mol. Biol. 47:237-252.
27. Ramos, C. R., M. M. Vilar, A. L. Nascimento, P. L. Ho, N. Thaumaturgo, R. Edelenyi, M. Almeida, W. O. Dias, C. M. Diogo, and M. Tendler. 2001. r-Sm14-pRSETA efficacy in experimental animals. Mem. Inst. Oswaldo Cruz 96(Suppl. 1):131-135.
28. Richter, D., R. N. Incani, and D. A. Harn. 1993. Isotype responses to candidate vaccine antigens in protective sera obtained from mice vaccinated with irradiated cercariae of Schistosoma mansoni. Infect. Immun. 61:3003-3011.
29. Stich, R. W., L. K. Shoda, M. Dreewes, B. Adler, T. W. Jungi, and W. C. Brown. 1998. Stimulation of nitric oxide production in macrophages by Babesia bovis. Infect. Immun. 66:4130-4136.
30. Stover, C. K., G. P. Bansal, M. S. Hanson, J. E. Burlein, S. R. Palaszynski, J. F. Young, S. Koenig, D. B. Young, A. Sadziene, and A. G. Barbour. 1993. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J. Exp. Med. 178:197-209.
31. Tendler, M., C. A. Brito, M. M. Vilar, N. Serra-Freire, C. M. Diogo, M. S. Almeida, A. C. Delbem, J. F. Da Silva, W. Savino, R. C. Garratt, N. Katz, and A. S. Simpson. 1996. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc. Natl. Acad. Sci. USA 93:269-273.
32. Tendler, M., M. M. Vilar, C. A. Brito, N. M. Freire, N. Katz, and A. Simpson. 1995. Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine? Mem. Inst. Oswaldo Cruz 90:255-256.